Literature DB >> 36127506

Metabolic parameters and thyroid hormones in relation to suicide attempts in patients with first-episode and drug-naive major depressive disorder with comorbid glucose disturbances: a large cross-sectional study.

Xue Li1, Shi Wang Chen1, XiaoE Lang2, Jie Li1, Xiang-Yang Zhang3.   

Abstract

The factors associated with suicide attempts in major depressive disorder (MDD) patients with comorbid glucose disturbances remain unclear. To the best of our knowledge, this is the first study with a large sample size to examine risk factors of suicide attempts in first-episode drug-naïve (FEDN) MDD patients with comorbid glucose disturbances, including clinically relevant factors, metabolic parameters, and thyroid hormone levels. A total of 1718 FEDN MDD patients were enrolled. The Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), and Positive and Negative Syndrome Scale (PANSS) were used to assess the clinical symptoms of patients. Fasting blood glucose, metabolic parameters, and thyroid hormone levels were measured. After controlling for HAMA and HAMD scores, the suicide attempt rate was 1.88 times higher in MDD patients with glucose disturbances than in MDD patients without glucose disturbances. Compared to non-suicide attempters, suicide attempters among the MDD patients with glucose disturbances had higher scores on HAMD and HAMA, PANSS positive symptoms, as well as higher levels of systolic and diastolic blood pressure, TC, LDL-C, thyroid stimulating hormone (TSH), TgAb, and thyroid peroxidases antibody (TPOAb). The combination of positive symptom score, HDL-C, systolic blood pressure, and marital status distinguished suicide attempters from non-suicide attempters. In addition, HAMA score, HAMD score, and TPOAb were associated with the number of suicide attempts in MDD patients with comorbid glucose disturbances. Our results suggest a high incidence of suicide attempts in MDD patients with comorbid glucose disturbances. Several clinically relevant factors, metabolic parameters, and thyroid hormone function have an impact on suicide attempts in MDD patients with comorbid glucose disturbances.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Glucose disturbances; Metabolic parameters; Suicide attempt; Thyroid hormones

Year:  2022        PMID: 36127506     DOI: 10.1007/s00406-022-01490-w

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.760


  64 in total

Review 1.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

Authors:  Harvey A Whiteford; Louisa Degenhardt; Jürgen Rehm; Amanda J Baxter; Alize J Ferrari; Holly E Erskine; Fiona J Charlson; Rosana E Norman; Abraham D Flaxman; Nicole Johns; Roy Burstein; Christopher J L Murray; Theo Vos
Journal:  Lancet       Date:  2013-08-29       Impact factor: 79.321

2.  Diagnostic and Statistical Manual of Mental Disorders (DSM).

Authors:  Dolores Elaine Battle
Journal:  Codas       Date:  2013

Review 3.  Biomarkers of Suicide Attempt Behavior: Towards a Biological Model of Risk.

Authors:  Katherin Sudol; J John Mann
Journal:  Curr Psychiatry Rep       Date:  2017-06       Impact factor: 5.285

4.  Relationship between a history of a suicide attempt and treatment outcomes in patients with depression.

Authors:  Sung-Wan Kim; Robert Stewart; Jae-Min Kim; Il-Seon Shin; Jin-Sang Yoon; Sung-Won Jung; Min-Soo Lee; Hyeon-Woo Yim; Tae-Youn Jun
Journal:  J Clin Psychopharmacol       Date:  2011-08       Impact factor: 3.153

5.  Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.

Authors:  Maurizio Fava; Jonathan E Alpert; Cheryl N Carmin; Stephen R Wisniewski; Madhukar H Trivedi; Melanie M Biggs; Kathy Shores-Wilson; Don Morgan; Terry Schwartz; G K Balasubramani; A John Rush
Journal:  Psychol Med       Date:  2004-10       Impact factor: 7.723

6.  Stroke disability and rehabilitation of stroke: World Health Organization perspective.

Authors:  Shanthi Mendis
Journal:  Int J Stroke       Date:  2013-01       Impact factor: 5.266

7.  Suicidal behaviour in a French Cohort of major depressive patients: characteristics of attempters and nonattempters.

Authors:  J-M Azorin; A Kaladjian; N Besnier; M Adida; E Hantouche; S Lancrenon; H Akiskal
Journal:  J Affect Disord       Date:  2009-10-01       Impact factor: 4.839

8.  The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010.

Authors:  Alize J Ferrari; Fiona J Charlson; Rosana E Norman; Abraham D Flaxman; Scott B Patten; Theo Vos; Harvey A Whiteford
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

9.  Major depressive disorder and suicide risk among adult outpatients at several general hospitals in a Chinese Han population.

Authors:  Haiyan Li; Xinni Luo; Xiaoyin Ke; Qing Dai; Wei Zheng; Chanjuan Zhang; Ryan M Cassidy; Jair C Soares; XiangYang Zhang; Yuping Ning
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.